Programmed Death Ligand-1 Blocker [EPC] - N0000193338
Pharmacologic Class Information
Pharmacologic Code | N0000193338 |
Pharmacologic Name | Programmed Death Ligand-1 Blocker |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Programmed Death Ligand-1 Blocker
The table contains 3 products whose active ingredient are classified under the same pharmacologic class Programmed Death Ligand-1 Blocker [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0310-4611 | Imfinzi | Non-Proprietary Name: Durvalumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
44087-3535 | Bavencio | Non-Proprietary Name: Avelumab | Injection, Solution, Concentrate | Intravenous | Emd Serono, Inc. | ACTIVE | |
0310-4500 | Imfinzi | Non-Proprietary Name: Durvalumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE |